Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 28-Sep 2022. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1390591000001116 | Relebactam monohydrate | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 1390601000001113 | Relebactam monohydrate (substance) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Relebactam monohydrate | Is a | Substance with beta-lactamase inhibitor mechanism of action | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Generic Recarbrio 500mg/500mg/250mg powder for solution for infusion vials | Has specific active ingredient | False | Relebactam monohydrate | Inferred relationship | Existential restriction modifier | |
| Recarbrio 500mg/500mg/250mg powder for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) | Has specific active ingredient | False | Relebactam monohydrate | Inferred relationship | Existential restriction modifier | |
| Recarbrio 500mg/500mg/250mg powder for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) 25 vial | Has specific active ingredient | False | Relebactam monohydrate | Inferred relationship | Existential restriction modifier | |
| Generic Recarbrio 500mg/500mg/250mg powder for solution for infusion vials 25 vial | Has specific active ingredient | False | Relebactam monohydrate | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR